Search results for query: *

There was just a presentation by Stacy Lindborg, Co-CEO of Brainstorm to Everything ALS that was held yesterday. She discusses the data on NurOwn, and goes into detail on the floor effect, biomarkers, etc. I expect they will post the recording soon

I don't disagree with you re: another trial - it does seem like that may end up being a requirement. Brainstorm has been presenting data over the last few months to argue their case - this presentation (attached, from the Brainstorm website Investors & Media - BrainStorm Cell Therapeutics -...

Nikki J, can you expand on your post? I'm rather new to all of this, so I don't feel I really understand the background with regard to NurOwn's therapy. It seems like there's a rather checked history that I have not been witness to, and am trying to understand. From my viewpoint they met...

We are in the process of trying to access to Relyvrio. My PALS has Express Scripts for prescriptions through employer - they declined the prescription saying that "There is unclear clinical benefit with Relyvrio and a lack of clinical efficacy data". We are in the process of appealing, but...

They've presented some compelling evidence that shows the treatment has a positive effect on multiple biomarkers. This presentation, titled "2022 ALS ONE Research Symposium: Brainstorm-Cell Therapeutics/NurOwn", with their Chief Development Officer Stacy Lindborg, PhD is a good review of their...

FYI that Zenwise product does not specify which strain of Lacticaseibacillus rhamnosus is included - the study was very specific that the HA-114 strain was the one to show an effect. If you are going to try taking a probiotic based on this study, I would recommend looking for the specific strain.

I have not searched extensively, but this product does list the specific probiotic strain cited in the study. Florahealth (commercial link removed) has a product "super-8-hi-potency-probiotic" It could be a waste of money. Their website does not provide information about where their...

I'm interested in what the company behind NP001 is going to do next - they haven't announced that they are yet going to run a phase 3 trial. They did put out a press release earlier this year that they were getting manufacturing ready. "The company expects to have product available by the end...

We've been having a similarly difficult time getting the oral radicava. First jumping through the hoops of getting the insurance to approve (Express Scripts), not understanding how JourneyMate is meant to help (they haven't really, except getting the $7500 co pay assistance), and now, trying to...